Related Experiment Video
Updated: Jun 5, 2026
09:58
A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
Published on: May 6, 2016
Erythropoietin receptor expression in normal and neoplastic choroid plexus
R Beschorner1, T Psaras, R Meyermann
1Institute for Brain Research, Tübingen, Germany.
Clinical Neuropathology
|December 24, 2010
Summary
Erythropoietin receptor (EpoR) is present in choroid plexus tumors (CPT), but at lower levels than in normal tissue. Further research is needed to determine if EpoR levels impact CPT survival outcomes.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- Erythropoietin receptor (EpoR) is expressed in the central nervous system and various human tumors, influencing apoptosis, tumor growth, and treatment resistance.
- EpoR expression is linked to poorer survival in high-grade gliomas and increased recurrence risk in meningiomas.
Purpose of the Study:
- To investigate the expression of EpoR in human choroid plexus tumors (CPT) and normal choroid plexus (CP).
- To determine if EpoR expression correlates with clinicopathological features in CPT.
Main Methods:
- Immunohistochemistry was used to assess EpoR expression in 57 CPT samples and 23 normal CP samples.
- Semi-quantitative scoring evaluated staining intensity, with validation through Western blot and RT-PCR in select cases.
Main Results:
- EpoR expression was detected in all normal and neoplastic CP samples.
- Significantly lower EpoR expression levels were observed in CPT compared to normal CP (p < 0.001).
Conclusions:
- EpoR expression in CPT is comparable to normal CP and other glial neoplasms.
- No significant correlation was found between EpoR expression and clinicopathological factors like age, gender, WHO grade, mitosis, or tumor recurrence.
- The association between EpoR levels in CPT and patient survival requires further investigation.
